ResearcherJilin UniversityNo recent work listed

Yuxin Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6649-9324; OpenAlex author ID A5100416075. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 1

Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper

Papers 2

Irisin Enhances Doxorubicin-Induced Cell Apoptosis in Pancreatic Cancer by Inhibiting the PI3K/AKT/NF-κB Pathway. Last author DOI 10.12659/msm.917625 ↗
Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway. Last author DOI 10.1038/s41598-018-33229-w ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jiayu Liu · 2 shared papers, 2018–2019 · strength 0.26
- Paper Irisin Enhances Doxorubicin-Induced Cell Apoptosis in Pancreatic Cancer by Inhibiting the PI3K/AKT/NF-κB Pathway. DOI 10.12659/msm.917625 ↗
- Paper Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway. DOI 10.1038/s41598-018-33229-w ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.